newsfilter
← Latest News
FDA Approved Drugs·

Approval of TOFACITINIB CITRATE, ANDA #220972

Approval Date: 11/06/2026 Drug Name: TOFACITINIB CITRATE, ANDA #220972 Submission: ORIG-2 Active Ingredients: TOFACITINIB CITRATE Company: SCIEGEN PHARMS Submission Status: Approval Application Number: 220972

Company
SCIEGEN PHARMS
Keywords
TOFACITINIB CITRATE